Teladoc CEO: Why Cigna buying MDLive was positive for us


A leader in telemedicine, Teladoc’s stock is on a slide. But company leaders expect that investors will come around as the company continues to grow, gain customers and retain existing patients.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.